Variant position: 410 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 475 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human HHSKLLVSGFWGVARHFNYV GDLMGSLAYCLACGGGHLLPY
Mouse HHSKLLVSGFWGVARHFNYT GDLMGSLAYCLACGGGHLLPY
Rat HRSKLLVSGFWGVARHFNYT GDLMGSLAYCLACGGGHLLPY
Bovine HHSKLLVSGFWGVARHFNYT GDLMGSLAYCLACGGGHLLPY
Xenopus laevis HYSKLMISGFWGVARHLNYT GDLMGSLAYCLACGFDHLLPY
Xenopus tropicalis HYSKLMISGFWGVARHLNYT GDLMGSLAYCLACGFDHLLPY
Zebrafish HKSKLMTSGFWGVARHMNYT GDLMGSLAYCLACGGNHLLPY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 475 7-dehydrocholesterol reductase
395 – 395 NADP; via amide nitrogen and carbonyl oxygen
400 – 400 NADP
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.
Witsch-Baumgartner M.; Fitzky B.U.; Ogorelkova M.; Kraft H.G.; Moebius F.F.; Glossmann H.; Seedorf U.; Gillessen-Kaesbach G.; Hoffmann G.F.; Clayton P.; Kelley R.I.; Utermann G.;
Am. J. Hum. Genet. 66:402-412(2000)
Cited for: VARIANTS SLOS SER-51; MET-93; PRO-99; HIS-107; PRO-109; ASP-147; MET-154; PRO-157; LEU-169; CYS-182; CYS-242; VAL-247; MET-281; ILE-289; GLY-311; TYR-311; HIS-324; LEU-326; GLN-352; TRP-352; ALA-353; CYS-362; TYR-380; ARG-380; SER-380; LEU-397; CYS-404; SER-404; HIS-408; SER-410; ARG-410; CYS-443; GLN-446; GLN-448; LYS-448 AND LEU-450;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.